Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iota-Carrageenan Eye Drops (NCX-4240) in Adenoviral Conjunctivitis
NCT03009799Phase 2Withdrawn
- Sponsor
- Nicox S.A.
- Start
- Jan 2017
- Primary completion
- Aug 2017
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Iota-carrageenan in adenoviral conjunctivitis, sponsored by Nicox S.A.. Planned start Jan 2017; status: withdrawn.
02
Drugs
Iota-carrageenan
03
Conditions
adenoviral conjunctivitis
Beyond the preview
Go deeper on NCT03009799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03009799.